Evolent Health, Inc.
EVH
$4.72
-$0.02-0.42%
NYSE
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 31.49% | 5.87% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 31.49% | 5.87% | |||
| Cost of Revenue | 38.60% | 11.04% | |||
| Gross Profit | -3.51% | -13.86% | |||
| SG&A Expenses | -6.04% | 16.97% | |||
| Depreciation & Amortization | 0.05% | -52.14% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 30.58% | 5.86% | |||
| Operating Income | 14.01% | -5.16% | |||
| Income Before Tax | 0.28% | 94.03% | |||
| Income Tax Expenses | 198.35% | 154.26% | |||
| Earnings from Continuing Operations | -6.50% | 93.79% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -6.50% | 93.79% | |||
| EBIT | 14.01% | -5.16% | |||
| EBITDA | 25.47% | -81.08% | |||
| EPS Basic | -5.88% | 93.81% | |||
| Normalized Basic EPS | 2.34% | 10.98% | |||
| EPS Diluted | -5.88% | 93.81% | |||
| Normalized Diluted EPS | 2.34% | 10.98% | |||
| Average Basic Shares Outstanding | 0.57% | 0.26% | |||
| Average Diluted Shares Outstanding | 0.57% | 0.26% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||